Analyst Reco. NuCana plc

Equities

NCNA

US67022C2052

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-20 pm EDT			5-day change	1st Jan Change
3.6 ^USD	+0.84%		-3.49%	-51.32%

May. 16	NuCana plc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

American Depositary Receipts of European Equities Advance Slightly Before US Rate Decision	23-03-22	MT
ECB, Bank of England Interest Rate Hikes Weigh Down European Equities	22-12-15	MT
Oppenheimer Trims NuCana's Price Target to $4 From $5, Maintains Outperform Rating	22-11-21	MT
Jefferies & Co. Adjusts NuCana's Price Target to $3 From $21, Keeps Buy Rating	22-09-22	MT
Truist Securities Adjusts NuCana's Price Target to $6 From $22, Reiterates Buy Rating	22-04-13	MT
Oppenheimer Adjusts NuCana Price Target to $5 From $19, Maintains Neutral Rating	22-03-14	MT
Cowen Downgrades NuCana to Market Perform From Outperform	22-03-03	MT
HC Wainwright Adjusts NuCana's Price Target to $9 From $10, Keeps Buy Rating	21-11-24	MT
NUCANA : HC Wainwright Adjusts NuCana's Price Target to $10 From $15, Keeps at Buy	20-12-01	MT
NuCana : Says Final Data From Phase Ib Trial of Advanced Biliary Tract Cancer Treatment Show High Objective Response Rate	20-11-30	MT
NUCANA : HC Wainwright Adjusts NuCana's Price Target to $15 From $17, Keeps at Buy	20-11-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW